These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 12773005)
41. Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry. Gifford KA; Horton JL; Jackson EF; Steger TR; Heard MP; Mourtada F; Lawyer AA; Ibbott GS Med Phys; 2005 Jul; 32(7):2288-94. PubMed ID: 16121584 [TBL] [Abstract][Full Text] [Related]
42. Dosimetric characterization of a brachytherapy applicator using MCNP5 modelisation and in-phantom measurements. Gerardy I; Ródenas J; van Dycke M; Gallardo S; Ceccolini E Appl Radiat Isot; 2010; 68(4-5):735-7. PubMed ID: 19939686 [TBL] [Abstract][Full Text] [Related]
43. A dosimetry method in the transverse plane of HDR Ir-192 brachytherapy source using gafchromic EBT2 film. Uniyal SC; Sharma SD; Naithani UC Phys Med; 2012 Apr; 28(2):129-33. PubMed ID: 21507693 [TBL] [Abstract][Full Text] [Related]
44. GAF film dosimetry of a tandem positioned beta-emitting intravascular brachytherapy source train. Iftimia I; Devlin PM; Chin LM; Baron JM; Cormack RA Med Phys; 2003 Jun; 30(6):1004-12. PubMed ID: 12852522 [TBL] [Abstract][Full Text] [Related]
45. Effects of off-centering on dose uniformity along and around blood vessels undergoing catheter-based intravascular brachytherapy. Nath R; Yue N Cardiovasc Radiat Med; 2004; 5(2):88-96. PubMed ID: 15464946 [TBL] [Abstract][Full Text] [Related]
46. Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy. Vijande J; Ballester F; Ouhib Z; Granero D; Pujades-Claumarchirant MC; Perez-Calatayud J Brachytherapy; 2012; 11(6):528-35. PubMed ID: 22226080 [TBL] [Abstract][Full Text] [Related]
47. Monte Carlo characterization of a new Yb-169 high dose rate source for brachytherapy application. Cazeca MJ; Medich DC; Munro JJ Med Phys; 2010 Mar; 37(3):1129-36. PubMed ID: 20384248 [TBL] [Abstract][Full Text] [Related]
48. EchoSeed Model 6733 Iodine-125 brachytherapy source: improved dosimetric characterization using the MCNP5 Monte Carlo code. Mosleh-Shirazi MA; Hadad K; Faghihi R; Baradaran-Ghahfarokhi M; Naghshnezhad Z; Meigooni AS Med Phys; 2012 Aug; 39(8):4653-9. PubMed ID: 22894389 [TBL] [Abstract][Full Text] [Related]
49. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source. Meigooni AS; Hayes JL; Zhang H; Sowards K Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937 [TBL] [Abstract][Full Text] [Related]
50. Monte Carlo calculations of dose distributions around 32P and 198Au stents for intravascular brachytherapy. Reynaert N; Verhaegen F; Taeymans Y; Van Eijkeren M; Thierens H Med Phys; 1999 Aug; 26(8):1484-91. PubMed ID: 10501047 [TBL] [Abstract][Full Text] [Related]
51. Validation of GPUMCD for low-energy brachytherapy seed dosimetry. Hissoiny S; Ozell B; Després P; Carrier JF Med Phys; 2011 Jul; 38(7):4101-7. PubMed ID: 21859010 [TBL] [Abstract][Full Text] [Related]
52. Monte Carlo dose calculations using MCNP4C and EGSnrc/BEAMnrc codes to study the energy dependence of the radiochromic film response to beta-emitting sources. Pacilio M; Aragno D; Rauco R; D'Onofrio S; Pressello MC; Bianciardi L; Santini E Phys Med Biol; 2007 Jul; 52(13):3931-48. PubMed ID: 17664586 [TBL] [Abstract][Full Text] [Related]
53. Dosimetric study of a new polymer encapsulated palladium-103 seed. Bernard S; Vynckier S Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339 [TBL] [Abstract][Full Text] [Related]
54. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source. Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277 [TBL] [Abstract][Full Text] [Related]
55. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant. Furstoss C; Reniers B; Bertrand MJ; Poon E; Carrier JF; Keller BM; Pignol JP; Beaulieu L; Verhaegen F Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804 [TBL] [Abstract][Full Text] [Related]
56. Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation. Wang J; Zhang H Med Phys; 2008 Apr; 35(4):1571-9. PubMed ID: 18491551 [TBL] [Abstract][Full Text] [Related]
57. Tissue inhomogeneity correction for brachytherapy sources in a heterogeneous phantom with cylindrical symmetry. Meigooni AS; Nath R Med Phys; 1992; 19(2):401-7. PubMed ID: 1584139 [TBL] [Abstract][Full Text] [Related]
58. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source. Sowards KT; Meigooni AS Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171 [TBL] [Abstract][Full Text] [Related]
59. Monte Carlo dose calculations of beta-emitting sources for intravascular brachytherapy: a comparison between EGS4, EGSnrc, and MCNP. Wang R; Li XA Med Phys; 2001 Feb; 28(2):134-41. PubMed ID: 11243335 [TBL] [Abstract][Full Text] [Related]
60. Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source. Daskalov GM; Löffler E; Williamson JF Med Phys; 1998 Nov; 25(11):2200-8. PubMed ID: 9829246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]